SDHB and Down syndrome: Alkylating agent temozolomide (TMZ), which has a similar safety profile and effects with dacarbazine showed a 50% partial response rate in SDHB carriers (n = 10) in a retrospective series which suggest that TMZ might be more effective against metastatic PPGLs in PGL4 syndrome [34].